Is Frontotemporal Dementia Hereditary? Genetic Risk
At a Glance
Frontotemporal dementia can run in families, but most cases are not caused by a known inherited mutation. If a parent has FTD, genetic counseling and testing the affected parent first can clarify risk; inheriting a variant does not guarantee developing the disease.
In this answer
3 sections
Frontotemporal dementia (FTD) can be hereditary, but not all cases are. If your parent has been diagnosed with FTD, it is completely natural to worry about your own risk. The short answer is that while FTD has a strong genetic component, the majority of cases are not passed directly from parent to child [1].
Based on clinical studies, approximately 30% to 40% of people with FTD have some family history of dementia, psychiatric conditions, or movement disorders like ALS [1][2]. However, only about 10% to 20% of all FTD cases are caused by a specific, identifiable genetic mutation that follows a clear inheritance pattern [3].
Understanding your personal risk starts with understanding the difference between the two main clinical categories of FTD: sporadic and familial.
Sporadic vs. Familial FTD
Sporadic FTD is a clinical label meaning the patient has no known family history of the disease. If your parent has been diagnosed with sporadic FTD, the likelihood of a recognizable inherited form is lower, but the risk is not zero [4]. A lack of known family history can sometimes be the result of small family sizes, relatives who died young from other causes, or misdiagnoses in previous generations [4]. Even in apparently sporadic cases, a small fraction (roughly 5% to 11%) are later found to carry an underlying genetic cause [3].
Familial FTD means that another blood relative (such as a grandparent, aunt, or uncle) has also experienced FTD or a related neurological condition [1]. If your parent has familial FTD, a genetic counselor will carefully evaluate your family tree (pedigree) to determine if a specific genetic mutation might be responsible.
The Major FTD Genes: C9orf72, GRN, and MAPT
When FTD is inherited, it is most often caused by a pathogenic variant (a disease-causing mutation) in one of three major genes [5]:
- C9orf72: The most common genetic cause of FTD. Rather than a simple mutation, this is usually a “repeat expansion” (a sequence of DNA that repeats too many times). It can cause FTD, ALS, or a combination of both [5].
- GRN (Progranulin): Variants in this gene often lead to behavioral or language-related symptoms [6].
- MAPT (Tau): Variants in this gene affect a brain protein called tau and are often highly penetrant in affected families [6].
These genes follow an autosomal dominant inheritance pattern [1]. This means that if your parent carries a confirmed pathogenic variant in one of these genes, there is a 50% chance they will pass that specific variant on to you [5]. This 50% chance applies independently to each child in the family.
Inheriting a Gene vs. Developing the Disease
It is crucial to understand that a 50% chance of inheriting the variant is not a 50% chance of developing FTD [7].
Even within the same family, genetic FTD is highly unpredictable due to age-dependent penetrance—meaning the chance of developing symptoms increases with age but is not absolute [7]. If you inherit a variant, the exact age you might develop symptoms, the type of symptoms you experience, and the severity of the disease can be entirely different from your parent’s experience [5]. Some family members might develop behavioral symptoms, others might develop ALS, and the age of onset can vary widely [1].
Why Genetic Counseling is Essential Before Testing
Because of the heavy emotional weight and uncertainty surrounding genetic FTD, medical guidelines strongly recommend consulting a certified genetic counselor before anyone in the family pursues genetic testing [8]. Predictive testing is generally treated as an adult decision, allowing you to weigh the risks and benefits for yourself [9].
Test the Affected Parent First
A genetic counselor will help you navigate a structured process that typically starts with the affected parent. The most informative first step is usually to test your parent, not you [8].
- If a variant is found: Doctors know exactly what specific gene to look for if you choose to be tested later.
- If no variant is found: A negative result in an affected parent means the test didn’t find a known cause. However, it does not completely eliminate genetic risk, as your parent might carry a gene science has not yet discovered, or the specific test may not have looked for certain complex variants (like the C9orf72 repeat expansion, which requires a specialized assay) [4][10].
- Variants of Uncertain Significance (VUS): Sometimes a test finds an anomaly, but scientists don’t yet know if it causes disease. A VUS should not be used for predictive testing in other family members [10].
Personal and Legal Considerations
A genetic counselor will also help you weigh the profound personal implications of predictive testing. While there is currently no proven treatment that prevents or delays inherited FTD, testing can inform reproductive planning, qualify you for clinical trials, and help you make long-term life choices [9].
Finding out you carry a genetic mutation can also impact your eligibility for certain types of insurance. In the United States, for example, laws like the Genetic Information Nondiscrimination Act (GINA) protect your health insurance and employment, but they generally do not protect life, disability, or long-term care insurance [11]. A genetic counselor can help you navigate these jurisdiction-specific legal and financial protections before you decide to test.
Common questions in this guide
How likely is frontotemporal dementia to be inherited?
If my parent has a gene linked to FTD, what is my risk?
Which genes are most often linked to inherited FTD?
Should I have genetic testing if my parent has frontotemporal dementia?
What does a variant of uncertain significance mean in FTD testing?
Could FTD genetic testing affect my insurance?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What specific type of genetic testing did my parent receive, and did it include a specialized assay for the C9orf72 repeat expansion?
- 2.Based on our extended family's history, would you classify my parent's case of FTD as sporadic or familial, and how does that impact our family's risk?
- 3.Can you refer our family to a certified genetic counselor who specializes in neurodegenerative diseases to discuss our options?
- 4.If a pathogenic variant is found in my parent, what are the exact steps and safeguards in place if I later decide I want to pursue predictive testing for myself?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (11)
- 1
Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia.
Benussi A, Padovani A, Borroni B
Frontiers in aging neuroscience 2015; (7()):171 doi:10.3389/fnagi.2015.00171.
PMID: 26388768 - 2
The clinical spectrum of sporadic and familial forms of frontotemporal dementia.
Woollacott IO, Rohrer JD
Journal of neurochemistry 2016; (138 Suppl 1()):6-31 doi:10.1111/jnc.13654.
PMID: 27144467 - 3
The genetic landscape of frontotemporal lobar degeneration: investigation of a diagnostic cohort of 2747 probands.
Cogan G, Houot M, Bogoin J, et al.
Brain : a journal of neurology 2026; (149(7)):2438-2448 doi:10.1093/brain/awaf423.
PMID: 41240362 - 4
Preferences for multigene panel testing for hereditary breast cancer risk among ethnically diverse BRCA-uninformative families.
Vicuña B, Delaney HD, Flores KG, et al.
Journal of community genetics 2018; (9(1)):81-92 doi:10.1007/s12687-017-0322-8.
PMID: 28971318 - 5
An update on genetic frontotemporal dementia.
Greaves CV, Rohrer JD
Journal of neurology 2019; (266(8)):2075-2086 doi:10.1007/s00415-019-09363-4.
PMID: 31119452 - 6
Differences in Motor Features of C9orf72, MAPT, or GRN Variant Carriers With Familial Frontotemporal Lobar Degeneration.
Tipton PW, Deutschlaender AB, Savica R, et al.
Neurology 2022; (99(11)):e1154-e1167 doi:10.1212/WNL.0000000000200860.
PMID: 35790423 - 7
Longitudinal Cognitive Changes in Genetic Frontotemporal Dementia Within the GENFI Cohort.
Poos JM, MacDougall A, van den Berg E, et al.
Neurology 2022; (99(3)):e281-e295 doi:10.1212/WNL.0000000000200384.
PMID: 35483895 - 8
Genetic Counseling and Testing for Alzheimer's Disease and Frontotemporal Lobar Degeneration: An Italian Consensus Protocol.
Bocchetta M, Mega A, Bernardi L, et al.
Journal of Alzheimer's disease : JAD 2016; (51(1)):277-91 doi:10.3233/JAD-150849.
PMID: 26901402 - 9
Who and Why? Requests for Presymptomatic Genetic Testing for Amyotrophic Lateral Sclerosis/Frontotemporal Dementia vs Huntington Disease.
Amador MDM, Gargiulo M, Boucher C, et al.
Neurology. Genetics 2021; (7(1)):e538 doi:10.1212/NXG.0000000000000538.
PMID: 33376800 - 10
Alzheimer's Disease and Frontotemporal Dementia: The Current State of Genetics and Genetic Testing Since the Advent of Next-Generation Sequencing.
Goldman JS, Van Deerlin VM
Molecular diagnosis & therapy 2018; (22(5)):505-513 doi:10.1007/s40291-018-0347-7.
PMID: 29971646 - 11
Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTD.
Benatar M, Heiman-Patterson TD, Cooper-Knock J, et al.
Journal of neurology, neurosurgery, and psychiatry 2025; (96(3)):209-218 doi:10.1136/jnnp-2024-334339.
PMID: 39572211
This page explains hereditary risk and genetic testing in frontotemporal dementia for informational purposes only and does not constitute medical advice. A neurologist and certified genetic counselor can help interpret your family history and discuss testing.
Get notified when new evidence is published on Frontotemporal dementia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.